Vanguard Capital Management
HALO icon

Vanguard Capital Management’s Halozyme HALO Stock Holding History

Vanguard Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$419M Buy
5,351,312
+80,094
+2% +$5.46M 0.01% 775
2026
Q1 		$341M Buy
+5,271,218
New +$372M 0.01% 794

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management's HALO Position: Q2 2026 in Review

Vanguard Capital Management increased its Halozyme (HALO) stake by 1.5% in Q2 2026, buying an estimated $5.46M and bringing the position to 5,351,312 shares worth $419M. The position accounts for 0.01% of the portfolio, ranked #775.

Vanguard Capital Management first reported a position in HALO in Q1 2026 and has held it in 2 quarters since. 629 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Vanguard Capital Management held 5,351,312 shares of Halozyme worth $419M as of Q2 2026.
  • Vanguard Capital Management bought 80,094 Halozyme shares in Q2 2026, an estimated $5.46M.
  • Halozyme made up 0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #775 holding.
  • Vanguard Capital Management first reported a position in Halozyme in Q1 2026 and has held it in 2 quarters since.
  • 629 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.